{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:39:48Z","timestamp":1768624788233,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10875-021-01012-8","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T10:43:23Z","timestamp":1616150603000},"page":"1208-1212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Humoral Immunodeficiency and Immune Globulin Replacement Therapy (IGRT) Usage in DiGeorge Syndrome"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-8240","authenticated-orcid":false,"given":"Sara H.","family":"Soshnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuhina","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jaip.2013.08.003","volume":"1","author":"SM Maggadottir","year":"2013","unstructured":"Maggadottir SM, Sullivan KE. The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). J Allergy Clin Immunol Pract. 2013;1:589\u201394.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1012_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1006\/clin.1997.4463","volume":"86","author":"KE Sullivan","year":"1998","unstructured":"Sullivan KE, Jawad AF, Randall P, Driscoll DA, Emanuel BS, McDonald-McGinn DM, et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11. 2 deletion syndromes. Clin Immunol Immunopathol. 1998;86:141\u20136.","journal-title":"Clin Immunol Immunopathol"},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jpeds.2012.06.018","volume":"161","author":"K Patel","year":"2012","unstructured":"Patel K, Akhter J, Kobrynski L, Gathman B, Davis O, Sullivan KE. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge syndrome. J Pediatr. 2012;161:950\u20133.","journal-title":"J Pediatr"},{"issue":"13","key":"1012_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1177\/0009922814565885","volume":"54","author":"PI Tam","year":"2015","unstructured":"Tam PI, McAllister SC. Vaccine responses and immunologic characteristics of pediatric patients with DiGeorge syndrome. Clin Pediatr. 2015;54(13):1290\u20132.","journal-title":"Clin Pediatr"},{"issue":"2, Supplement","key":"1012_CR5","doi-asserted-by":"publisher","first-page":"AB8","DOI":"10.1016\/j.jaci.2012.12.704","volume":"131","author":"SM Maggadottir","year":"2013","unstructured":"Maggadottir SM, Maurer KA, Sullivan KE. Defective B-cell maturation in chromosome 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2013;131(2, Supplement):AB8.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1012_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s10875-014-0028-1","volume":"34","author":"KE Sullivan","year":"2014","unstructured":"Sullivan KE, Puck JM, Notarangelo LD, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol. 2014;34(4):428.","journal-title":"J Clin Immunol"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s10875-015-0196-7","volume":"35","author":"FO Seeborg","year":"2015","unstructured":"Seeborg FO, Seay R, Boyle M, Boyle J, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015;35:638\u201350. https:\/\/doi.org\/10.1007\/s10875-015-0196-7.","journal-title":"J Clin Immunol"},{"key":"1012_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/clinchem\/28.1.126","volume":"28","author":"CR Jolliff","year":"1982","unstructured":"Jolliff CR, Cost KM, Stivrins PC, Grossman PP, Nolte CR, Franco SM, et al. Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem. 1982;28:126\u20138.","journal-title":"Clin Chem"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01012-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T02:04:50Z","timestamp":1627265090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01012-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01012-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"29 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval was granted by Connecticut Children\u2019s Medical Center (CCMC) in Hartford Connecticut. The research was judged exempt from review and consent was not required due to the nature of it being a retrospective study of non-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"NB is a speaker\/consultant for Horizon Pharma (maker of Actimmune) and has clinical trial support from Baxalta (makers of Gammagard, Cuvitru and Hyqvia). SS and TJ have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}